Analysis of Risk Factors and Development and Validation of A Predictive Model for Intrapartum Fever in Pregnant Women Receiving Epidural Analgesia During Labor

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100049319

Enrollment

Unknown

Registered

2021-07-30

Start date

2021-11-01

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intrapartum fever

Interventions

Gold Standard:Clinical outcome

Index test:risk&#32

prediction&#32

model

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1.Single term pregnancy, pregnant woman; 2.Voluntary implementation of epidural analgesia vaginal delivery.

Exclusion criteria

Exclusion criteria: 1.Patients with cold, fever(body temperature > 37.5 ?) or upper respiratory tract infection before labor analgesia; 2.Use antibiotics or antipyretics, non steroidal anti-inflammatory drugs or glucocorticoids within 24 hours before analgesia; 3.Patients change from non intrapartum fever factors to cesarean section; 4.Allergic to ropivacaine or sufentanil; 5.Patients lack information.

Design outcomes

Primary

Measure	Time frame
Incidence of intrapartum fever;	—

Secondary

Measure	Time frame
Baseline maternal data;Delivery record;Labour progress;Implementation of analgesia;	—

Countries

China

Contacts

Public ContactZuo Yunxia

zuoyunxia@scu.edu.cn+86 18980601541

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026